Semaglutide is not directly nephrotoxic, but lupus patients with glomerulonephritis or reduced kidney function need baseline eGFR testing and periodic monitoring
Gastrointestinal (GI) side effects in patients, such as nausea, diarrhea, abdominal discomfort, or constipation, can occur with both drugs
Troubleshooting common conversion problems Even with charts and formulas, real-world dosing produces questions that the math alone does not answer
What are digestive enzymes: How to test your patients levels
Across phenotypes, our data indicate an association between rs1800437 and tirzepatide treatment for both the vomiting and nausea phenotypes, and potentially constipation, but the variant does not seem to influence efficacy ( P = 0.73